Prognostic Value of 2-Deoxy-2-[¹⁸F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores

Table 1

Patient characteristics (N = 76).

Characteristics	No.
Sex
Male	51
Female	25
Age (range)	34 (12–70)
Type of lymphoma
HL	14
B-cell NHL	37
T-cell NHL	25
Median follow-up, month (range)	24 (4–120)
Number of previous treatments
1	37
≥2	39
Ann Arbor stage
I-II	17
III-IV	59
Extranodal lesions
<2	49
≥2	27
LDH
≤ULN	61
>ULN	15
ECOG PS
<2	74
≥2	2
Conditioning regimen
BEAM	56
BuCy	10
Others	10
Status at SCT
CR + PR	59
SD + PD	17
Post-auto-SCT FDG PET-CT
Negative (DS < 4)	49
Positive (DS = 4 or 5)	27
Timing of post-auto-SCT FDG PET-CT
Within 3 months	43
Within 3–6 months	33

HL, Hodgkin’s lymphoma; NHL, non-Hodgkin’s lymphoma; SCT, stem cell transplantation; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ULN, upper laboratory limit; ECOG PS, Eastern Cooperative Oncology Group performance status; FDG, fluorodeoxyglucose; DS, Deauville score; PET, positron emission tomography; CT, computed tomography.